Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria Ejmont"'
Autor:
Joanna Trubicka, Maria Łastowska, Agnieszka Karkucińska-Więckowska, Magdalena Niemira, Maria Ejmont, Agnieszka Sowińska, Maciej Pronicki, Ewa Matyja, Wiesława Grajkowska
Publikováno v:
Folia Neuropathologica, Vol 61, Iss 2, Pp 121-128 (2023)
BCOR is expressed in a new brain tumour entity, i.e. ‘CNS tumour with BCOR internal tandem duplication’ (HGNET BCOR) but not in several other high grade paediatric brain tumours investigated. Immunohistochemical detection of BCOR expression may t
Externí odkaz:
https://doaj.org/article/a8029630c0e24ea59e0970ff420734b2
Autor:
Maria Łastowska, Ewa Matyja, Anna Sobocińska, Bartosz Wojtaś, Magdalena Niemira, Anna Szałkowska, Adam Krętowski, Agnieszka Karkucińska‐Więckowska, Magdalena Kaleta, Maria Ejmont, Magdalena Tarasińska, Marta Perek‐Polnik, Bożenna Dembowska‐Bagińska, Maciej Pronicki, Wiesława Grajkowska, Joanna Trubicka
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 565-576 (2021)
Abstract The majority of supratentorial ependymomas in children contain oncogenic fusions, such as ZFTA–RELA or YAP1‐MAMLD1. In contrast, posterior fossa (PF) ependymomas lack recurrent somatic mutations and are classified based on gene expressio
Externí odkaz:
https://doaj.org/article/7e8570c907ad436eb02c29b0dbf990be
Autor:
Maria Łastowska, Joanna Trubicka, Anna Sobocińska, Bartosz Wojtas, Magdalena Niemira, Anna Szałkowska, Adam Krętowski, Agnieszka Karkucińska-Więckowska, Magdalena Kaleta, Maria Ejmont, Marta Perek-Polnik, Bożenna Dembowska-Bagińska, Wiesława Grajkowska, Ewa Matyja
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-14 (2020)
Abstract Four molecular types of rare central nervous system (CNS) tumors have been recently identified by gene methylation profiling: CNS Neuroblastoma with FOXR2 activation (CNS NB-FOXR2), CNS Ewing Sarcoma Family Tumor with CIC alteration (CNS EFT
Externí odkaz:
https://doaj.org/article/2e546f93b82242a08cc7a0821eda5563
Autor:
Agnieszka Sowińska, Yasser Morsy, Elżbieta Czarnowska, Beata Oralewska, Ewa Konopka, Marek Woynarowski, Sylwia Szymańska, Maria Ejmont, Michael Scharl, Joanna B. Bierła, Marcin Wawrzyniak, Bożena Cukrowska
Publikováno v:
Cells, Vol 9, Iss 2, p 516 (2020)
Disruption of epithelial junctional complex (EJC), especially tight junctions (TJ), resulting in increased intestinal permeability, is supposed to activate the enhanced immune response to gluten and to induce the development of celiac disease (CD). T
Externí odkaz:
https://doaj.org/article/109d0220e2774b669693de25c8a90bbc
Autor:
Magdalena Kaleta, Ewa Matyja, Anna Szalkowska, Bartosz Wojtaś, Maciej Pronicki, Wiesława Grajkowska, Agnieszka Karkucinska-Wieckowska, Joanna Trubicka, Magdalena Niemira, Bożenna Dembowska-Bagińska, Magdalena Tarasińska, Marta Perek-Polnik, Maria Łastowska, Anna A. Sobocińska, Adam Kretowski, Maria Ejmont
Publikováno v:
The Journal of Pathology: Clinical Research
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 565-576 (2021)
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 565-576 (2021)
The majority of supratentorial ependymomas in children contain oncogenic fusions, such as ZFTA–RELA or YAP1‐MAMLD1. In contrast, posterior fossa (PF) ependymomas lack recurrent somatic mutations and are classified based on gene expression or meth
Autor:
Ewa Matyja, Bożenna Dembowska-Bagińska, Anna A. Sobocińska, Magdalena Niemira, Maria Łastowska, Marta Perek-Polnik, Wiesława Grajkowska, Bartosz Wojtas, Adam Kretowski, Joanna Trubicka, Agnieszka Karkucinska-Wieckowska, Magdalena Kaleta, Maria Ejmont, Anna Szalkowska
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-14 (2020)
Acta Neuropathologica Communications
Acta Neuropathologica Communications
Four molecular types of rare central nervous system (CNS) tumors have been recently identified by gene methylation profiling: CNS Neuroblastoma with FOXR2 activation (CNS NB-FOXR2), CNS Ewing Sarcoma Family Tumor with CIC alteration (CNS EFT-CIC), CN
Autor:
Agnieszka Sowińska, Rafał Płoski, Wiesława Grajkowska, Joanna Trubicka, Maria Łastowska, Marta Perek-Polnik, Magdalena Kozłowska, Bożenna Dembowska-Bagińska, Małgorzata Rydzanicz, Maria Ejmont, Maciej Pronicki
Publikováno v:
Neuro-Oncology
INTRODUCTION Glioblastoma (GBM) remains one of the biggest therapeutic challenges in neuro-oncology. In spite of multimodal treatment approaches the prognosis of GBM is extremely poor, median survival is estimated about 12–16 months. Although GBM i